Symber Bio-Fabs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 28-12-2024
- Paid Up Capital ₹ 0.10 M
as on 28-12-2024
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 6.00 M
as on 28-12-2024
- Revenue -48.66%
(FY 2020)
- Profit -89.94%
(FY 2020)
- Ebitda -116.90%
(FY 2020)
- Net Worth 9.22%
(FY 2020)
- Total Assets 245.37%
(FY 2020)
About Symber Bio-Fabs
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.00 M.
Bimal Kumar and Aarthi Balamuralikrishna serve as directors at the Company.
- CIN/LLPIN
U74999TN2016PTC111840
- Company No.
111840
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Aug 2016
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Vellore, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Symber Bio-Fabs Private Limited offer?
Symber Bio-Fabs Private Limited offers a wide range of products and services, including Architectural & Civil Engineering, Architectural Services, Chemical Reactors and Process Tanks, Septic Tanks, Portable Toilets, Mobile Toilets, Doors and Windows, Fiber Door, Wash Basins, Sanitaryware & Fittings, Sanitary Fittings.
Who are the key members and board of directors at Symber Bio-Fabs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bimal Kumar  | Director | 05-Aug-2016 | Current |
| Aarthi Balamuralikrishna | Director | 05-Aug-2016 | Current |
Financial Performance of Symber Bio-Fabs.
Symber Bio-Fabs Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 48.66% decrease. The company also saw a substantial fall in profitability, with a 89.94% decrease in profit. The company's net worth moved up by a moderate rise of 9.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Symber Bio-Fabs?
In 2020, Symber Bio-Fabs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 01 Jun 2020 | ₹6.00 M | Open |
How Many Employees Work at Symber Bio-Fabs?
Unlock and access historical data on people associated with Symber Bio-Fabs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Symber Bio-Fabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Symber Bio-Fabs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
